By n The Associated Pressn
Posted October 31, 2025 3:01 am
Updated October 31, 2025 4:29 am
1 min read
Descrease article font size
Increase article font size
The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.
New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.
Related Videos
4:15
North Vancouver man with an ostomy running Squamish ultra-marathon
Previous Video
Next Video
Trending Now
-
Carney is set to announce immigration plan. Where do levels stand now?
-
Truck driver industry crackdown coming in budget to target ‘Drivers Inc.’
Story continues below advertisement
Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday.
The FDA said in enforcement orders posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.
According to the FDA, N-nitrosamine impurities are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.
More on Health
More videos
© 2025 The Canadian Press
